Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 216 results for "Byetta"

Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics...

Byetta Lawsuit News: New Order Issued in Federal Incretin Mime...

The Firm is evaluating Byetta lawsuits and other legal claims that allege the use of diabetes drugs called incretin mimetics caused patients to develop pancreatic cancer, pancreatitis or thyroid cancer. New York, New York (PRWEB) October 08, 2014 ..., 2 weeks ago

Human medicines European public assessment report (EPAR): Byetta, exenatide, Revision: 14, Authorised

This is a summary of the European public assessment report (EPAR) for Byetta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency1 month ago

Byetta Lawsuits Move Forward, With New Ruling Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Reports

Byetta lawsuits( and other product liability claims that allege incretin mimetic Type 2 diabetes medications caused patients to develop pancreatic cancer continue to move forward in U.S. courts, Bernstein Liebhard LLP ...
 Digital Journal4 weeks ago Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases  Digital Journal1 month ago Byetta Lawsuit News: Bernstein Liebhard LLP Notes British Columbia's Recent Decision to Discontinue Incretin Mimetic Drug Coverage from PharmaCare Program  Digital Journal2 months ago

AZs Byetta on par with Lillys Humalog in sugar control

Adding AstraZeneca's Byetta (exenatide) to basal insulin glargine/meformin is just as effective at lowering blood sugar in adults with type II diabetes as adding bolus insulin
 Big News Network4 weeks ago Diabetes drug exenatide as effective as bolus insulin in new study results  GM Journal1 month ago AstraZeneca's Byetta meets primary endpoint in diabetes trial and reduces weight  Pharma Letter1 month ago

Engineer II, Device Engineering

Candidate Focus & Challenge The role holder is a member of the Device Technical Services team in Technical Operations, in West Chester Operations. The Device Technical Services team is responsible for 1st line Technical support and compliance of ...
 PharmaDiversity1 week ago

Adamis Pharmaceuticals Announces Key Additions to Medical and Commercial Teams

SAN DIEGO, Oct. 15, 2014 (GLOBE NEWSWIRE) -- (Nasdaq:ADMP) today announced key additions to its medical and product marketing management teams. These new employees position the company for further development of its product pipeline and the ...
 EMoneyDaily1 week ago Adamis Pharmaceuticals : Announces Key Additions to Medical and Commercial Teams  4 Traders1 week ago

How Pharma's Landlord Could Benefit From The Drug Boom

In Manhattan, overlooking the East River and sandwiched between New York University Langone Medical Center and Bellevue Hospital, two gleaming 16-story towers act as beacons to the booming biotech sector. Completed in 2010, the ...
 Forbes.com1 week ago How The Drug Boom May Benefit Pharma's Landlord  Forbes.com1 week ago

Rotator Cuff Disease

GENERIC NAME: cefprozil BRAND NAME: Cefzil DRUG CLASS AND MECHANISM: Cefprozil is a semi-synthetic (partially man-made), oral antibiotic of the cephalosporin family. The cephalosporin family includes cephalexin (Keflex), cefaclor ...
 MedicineNet.com1 week ago
Advance for Nurses

GLP-1 Agonist Therapy

Pharmacologic management of hyperglycemia associated with type 2 diabetes mellitus (T2DM) can be complex and challenging for both healthcare providers and patients. 1 A wide array of treatment options are available, starting with lifestyle ...
 Advance for Nurses1 week ago 2 Reasons Why Eli Lilly's New Diabetes Drug Might Not Become A Blockbuster  Seeking Alpha4 weeks ago Eli Lilly receives FDA approval for treatment option of type 2 diabetes  Individual.com1 month ago Eli Lilly's Trulicity receives US FDA approval to treat adults with type 2 diabetes  PharmaBiz1 month ago
Jutia Group

Stock Update (NYSE:BMY): UPDATE 1-Bristol-Myers pulls U.S. marketing application for hepatitis C treatment

[Reuters] Bristol-Myers Squibb said it withdrew its U.S. Bristol-Myers is racing against Merck & Co and AbbVie to try and cut the treatment time by half and avoid side effects from older standard drugs interferon and ribavirin. Bristol-Myers ...
 Jutia Group2 weeks ago Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) Bristol-Myers Squibb to Transfer $1.4 Billion in U.S. Pension Obligations to Prudential  Jutia Group3 weeks ago Market Update: Bristol-Myers Squibb Company (NYSE:BMY) Bristol-Myers Squibb Presents Data from Multiple New Studies at IDWeek 2014 Showcasing Continued Innovation in Virology  Jutia Group3 weeks ago Stock Update (NYSE:BMY): Bristol immunotherapy gets 6-month U.S. FDA review for melanoma  Jutia Group4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less